highlighted the role of MUC1 and MUC16 in breast and pancreatic cancer cells, showing that reducing their expression through COSMC gene knockdown enhances tumor cell sensitivity to natural killer cell-mediated antibody-dependent cellular cytotoxicity (ADCC) and cytotoxic T lymphocyte (CTL) killing. This evidence concerns the gene MUC1 and pancreatic neoplasm.